// August 29, 2023
Part two: Industry examining FDA guidance on nitrosamines
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies fro
// August 23, 2023
Part One: Industry examining FDA guidance on nitrosamines
Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as t
// March 07, 2023
Nitrosamine Impurities: Latest USP Tool Further Aids Understanding and Control
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
